VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Emerging Prognostic Markers Continue to Improve Myeloma Treatment

Emerging Prognostic Markers Continue to Improve Myeloma Treatment

Newly-discovered and future biomarkers are likely to help oncologists give an accurate prognosis and to prescribe more effective treatment for patients with multiple myeloma.

Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC

Immune Checkpoint Inhibitors Continue to Transform Management of Advanced NSCLC

Immunotherapy may be effective for some patients with NSCLC as a second-line treatment, but it's unclear the role it will have in the first-line.

Treating TKI-induced Hypertension in Renal Cell Carcinoma

Treating TKI-induced Hypertension in Renal Cell Carcinoma

Inhibiting the VEGF signaling pathway can cause hypertension; there are, however, limited data on managing kinase inhibitor-induced hypertension.

Minimal Residual Disease and Treatment Response in Multiple Myeloma

Minimal Residual Disease and Treatment Response in Multiple Myeloma

A newly released survey of clinical testing finds that widely divergent methodologies for MRD testing remain a continuing challenge.

2016 Concordia Summit: The Future of Immunotherapy

2016 Concordia Summit: The Future of Immunotherapy

Speakers at the 2016 Concordia Summit's panel, "Precision Medicine in Cancer Research," discussed the importance and future of immunotherapy for cancer treatment.

Assessing Mindfulness-based Cognitive Therapy For Cancer Pain

Assessing Mindfulness-based Cognitive Therapy For Cancer Pain

Researchers are attempting to determine the usefulness of mindfulness for cancer pain.

Enforcing Reproducibility Improves the Accuracy of Scientific Predictions

Enforcing Reproducibility Improves the Accuracy of Scientific Predictions

Overselling scientific data contributes to misunderstanding, failure, and disappointment in real-world settings.

Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma

Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma

Novel targeted and immunological therapies may help improve the outlook for patients with renal cell carcinoma (RCC).

Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer?

Checkpoint Inhibitors and Combination Therapy: the Future of Treatment for Non-small Cell Lung Cancer?

While immune checkpoint inhibitors show real promise for treating lung cancer, better predictive biomarkers are necessary to make the therapy more effective.

Breast Cancer Risk and Psychosocial Adjustment Among Adolescents

Breast Cancer Risk and Psychosocial Adjustment Among Adolescents

Breast cancer-specific distress, though offset by psychosocial adjustment, is higher among adolescents at high risk of developing breast cancer.

VEGF/mTOR-directed Combination Shows Promise in Renal Cell Carcinoma

VEGF/mTOR-directed Combination Shows Promise in Renal Cell Carcinoma

It is the responsibility of investigators to develop randomized trials that investigate rare subtypes of RCC, according to an editorial.

Whole Brain Radiotherapy Offers Little Benefit to Patients With Brain-metastatic Lung Cancer

Whole Brain Radiotherapy Offers Little Benefit to Patients With Brain-metastatic Lung Cancer

Whole brain radiotherapy does not improve overall survival or quality of life among patients with brain-metastatic lung cancer.

Breast Density and Risk Factors Indicate Breast Cancer Screening Intervals

Breast Density and Risk Factors Indicate Breast Cancer Screening Intervals

Authors of a modeling study recommend triennial mammography for 12% of women aged 50 years, and 20% aged 65 years with low breast density and few or no risk factors.

Air Pollution May Affect Survival of Lung Cancer

Air Pollution May Affect Survival of Lung Cancer

An analysis of over 20 years of health data indicates that exposure to air pollution is correlated with worsened survival outcomes for patients diagnosed with lung cancer.

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

Relationship Between Mutant KRAS and ACLS3 Opens Door to Therapy Development for NSCLC

Research has uncovered a potential treatment target for mutant KRAS non-small cell lung cancer: Acyl-Coenzyme A synthetase long chain family member 3.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters